As part of our ongoing series, each week we typically conduct a DCF on one of the companies in our screens. This week, we’re analyzing a global leader in quick-service dining — Domino’s Pizza Inc (DPZ).| The Acquirer's Multiple®
This week’s best investing news:| The Acquirer's Multiple®
As part of our ongoing series here at The Acquirer’s Multiple, each week we spotlight a stock from our Stock Screeners that might be a deeply undervalued gem hiding in plain sight.| The Acquirer's Multiple®
During their recent episode, Taylor, Carlisle, and Jim and Abigail Zimmerman discussed What Ribosomes Can Teach Us About the Future of Manufacturing. Here’s an excerpt from the episode:| The Acquirer's Multiple®
In The Little Book That Still Beats the Market, Joel Greenblatt distills decades of experience into a concise, witty, and surprisingly approachable framework for beating the market. At its core, Greenblatt introduces what he calls the “Magic Formula”—a systematic way to buy good companies at bargain prices.| The Acquirer's Multiple®
In a recent interview with CNBC, legendary value investor Mario Gabelli, chairman and CEO of Gamco Investors, shared his unfiltered views on today’s market dynamics. He dissects opportunities with his trademark blend of financial acumen and street smarts.| The Acquirer's Multiple®
Each week, we unpack the latest high-conviction trades from legendary investors — revealing what they’re doubling down on, cutting loose, or quietly walking away from.| The Acquirer's Multiple®
During their recent episode, Taylor, Carlisle, and Jim and Abigail Zimmerman discussed Avoiding Value Traps by Tracking Free Cash Flow. Here’s an excerpt from the episode:| The Acquirer's Multiple®
In his interview with David Rubenstein, renowned value investor Chris Davis highlights a critical but often overlooked factor in investing success: behavior. Davis argues that the greatest obstacle to consistent returns isn’t market swings or stock selection—it’s how investors react to them.| The Acquirer's Multiple®
In a recent episode of The Long View podcast, Cliff Asness, founder and CIO of AQR Capital Management, shared his sharp thoughts on tariffs, market-timing, and the allure of private equity—topics that resonate deeply with investors navigating complex markets.| The Acquirer's Multiple®
This week’s large-cap value screener reveals a select group of stocks offering a compelling blend of low valuation, strong free cash flow, and high shareholder returns.| The Acquirer's Multiple®
During their recent episode, Taylor, Carlisle, and Jim and Abigail Zimmerman discussed Fort Knox Balance Sheets Help You Sleep at Night. Here’s an excerpt from the episode:| The Acquirer's Multiple®
After months of underperformance, value stocks—especially in the small-cap space—are staging a quiet comeback. But growth, particularly in the large-cap segment, remains firmly in the driver’s seat. The latest performance data from Seeking Alpha on U.S. Equities across the S&P Indexes highlights a tale of two narratives: a long-term dominance by growth stocks and a short-term surge in value names.| The Acquirer's Multiple®
In their latest Q2 2025 commentary, Pzena Investment Management offers a sober but optimistic perspective for long-term investors confronting heightened volatility. “The second quarter was a wild ride for global equity markets,” they write, citing early-quarter declines sparked by trade-war fears and later volatility due to Middle East tensions.| The Acquirer's Multiple®
In a recent interview, Ray Dalio’s analysis reveals a looming economic reckoning most investors are ignoring. “The US government spends $7 trillion a year. It takes in $5 trillion a year,” he explains, painting a stark picture of unsustainable deficits. The result? A “supply of debt that the US will have to sell is about $12 trillion” annually—a tidal wave of borrowing that risks triggering an “economic heart attack.”| The Acquirer's Multiple®
In the most recently reported quarter, several renowned institutional investors made notable increases to their Danaher (DHR) holdings, reflecting growing confidence in the life sciences and diagnostics conglomerate. As the company continues to evolve its portfolio through innovation and strategic divestitures, Danaher is attracting fresh institutional capital as a long-term compounder in the healthcare sector.| The Acquirer's Multiple®
